In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in ...

"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising path toward a new therapeutic tool against HBV," says Viviana I. Risca, head ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

The research team determined that in order for a critical protein to get made, the hepatitis B virus’s DNA needs to get organized into these DNA-histone complexes. Preventing this from happening ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

Researchers identify a history of GI bleeding and three other factors as elevating variceal bleeding risk in patients ...

To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with ...

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...